Related Experiment Videos
Future expectations for critical care nurses. Competence in immunotherapy
Critical Care Nursing Clinics of North America
|December 1, 1989
Summary
Immunotherapy using interleukin-2 (IL-2) shows promise for cancer treatment but can cause severe side effects. Critical care nurses play a vital role in managing patients experiencing these toxicities.
Area of Science:
- Oncology
- Immunology
- Critical Care Medicine
Background:
- Immunotherapy, utilizing substances like interleukin-2 (IL-2), is an emerging cancer treatment strategy.
- This approach harnesses the immune system to target tumor cells while minimizing damage to healthy tissues.
Observation:
- Interleukin-2 (IL-2) therapy is associated with a range of adverse effects.
- Severe toxicities primarily impact the cardiovascular, renal, and pulmonary systems.
- Patients experiencing IL-2-related toxicities require intensive care unit (ICU) management.
Findings:
- Effective management of IL-2 toxicities is achievable within the ICU setting.
- Critical care nurses are essential in monitoring and managing patients undergoing immunotherapy.
- The increasing adoption of immunotherapy research necessitates enhanced critical care nursing expertise.
Implications:
- Critical care nurses require specialized knowledge and skills for immunotherapy patient management.
- Hospitals offering IL-2 research treatments must ensure adequate critical care support.
- Competency in immunotherapy patient care will become a standard expectation for critical care nurses.